Merck KGaA (Merck KGaA) Net Margin %

: 11.22% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Merck KGaA's Net Income for the three months ended in Dec. 2023 was $639 Mil. Merck KGaA's Revenue for the three months ended in Dec. 2023 was $5,698 Mil. Therefore, Merck KGaA's net margin for the quarter that ended in Dec. 2023 was 11.22%.

The historical rank and industry rank for Merck KGaA's Net Margin % or its related term are showing as below:

MKKGY' s Net Margin % Range Over the Past 10 Years
Min: 8.17 Med: 12.39 Max: 22.74
Current: 13.46

MKKGY's Net Margin % is ranked better than
77.16% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.765 vs MKKGY: 13.46

Merck KGaA Net Margin % Historical Data

The historical data trend for Merck KGaA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

8.17

11.33

15.52

14.96

13.45

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																11.57	15.04	13.28	14.29	11.22

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Net Margin % falls into.

Merck KGaA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Merck KGaA's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	3079.607	/	22893.13
	=	13.45 %

Merck KGaA's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	639.04	/	5697.928
	=	11.22 %

Merck KGaA (OTCPK:MKKGY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Merck KGaA Net Margin % Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.